Des Moines, IA, Feb. 08, 2017 --
|
|||||
DES MOINES, IA (February 8, 2017)—Founders David Miles and Matt Kinley announced today the launch of ManchesterStory Group, a venture capital firm backed by a consortium of leading insurance companies from across the country.
ManchesterStory’s investment strategy targets early to growth-stage investments in FinTech and Healthcare, with a particular interest in technologies spurring innovation in the insurance industry. ManchesterStory expects to be attractive to entrepreneurs seeking to benefit from the firm’s experience in helping startups to succeed, as well as the opportunity to form key industry relationships.
An active investor in Healthcare & FinTech for the last twenty-two years, Matt Kinley stated, “We see tremendous investment opportunity in our target sectors, which together comprise 25% of the U.S. economy. Each has significant potential for digital transformation, and both are integrally connected to and impacted by insurance.”
Dave Miles, a thirty-year insurance investment veteran, commented “Across the financial services landscape, traditional players are adopting and/or being disrupted by digital innovations that are being demanded by their customers. Technologies that improve customer engagement, decision-making, and back-end efficiencies, are improving the entire value chain. ManchesterStory is ideally positioned to bring together industry leaders and startups around capital and strategy.”
ManchesterStory is actively seeking investment opportunities across the U.S. For more information, please visit www.manchesterstory.com.
About ManchesterStory Group
ManchesterStory Group is a venture capital firm targeting investments in FinTech and Healthcare, with a particular interest in technologies impacting the insurance industry. Focused on early to growth-stage companies across the United States, ManchesterStory Group seeks to generate superior returns by connecting exceptional entrepreneurs to strategic capital and relationships.
Media Contact: Ben Handfelt Phone: 515-453-2109 Email: [email protected]


JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands 



